nodes	percent_of_prediction	percent_of_DWPC	metapath
Zanamivir—Chills—Etoposide—peripheral nervous system neoplasm	0.00185	0.00185	CcSEcCtD
Zanamivir—Shock—Alitretinoin—peripheral nervous system neoplasm	0.00184	0.00184	CcSEcCtD
Zanamivir—Musculoskeletal discomfort—Dactinomycin—peripheral nervous system neoplasm	0.00184	0.00184	CcSEcCtD
Zanamivir—Hypersensitivity—Topotecan—peripheral nervous system neoplasm	0.00184	0.00184	CcSEcCtD
Zanamivir—Hypersensitivity—Tretinoin—peripheral nervous system neoplasm	0.00182	0.00182	CcSEcCtD
Zanamivir—Hypersensitivity—Isotretinoin—peripheral nervous system neoplasm	0.00182	0.00182	CcSEcCtD
Zanamivir—Skin disorder—Alitretinoin—peripheral nervous system neoplasm	0.00182	0.00182	CcSEcCtD
Zanamivir—Ill-defined disorder—Cisplatin—peripheral nervous system neoplasm	0.00182	0.00182	CcSEcCtD
Zanamivir—Anaphylactic shock—Vincristine—peripheral nervous system neoplasm	0.00181	0.00181	CcSEcCtD
Zanamivir—Hypersensitivity—Melphalan—peripheral nervous system neoplasm	0.0018	0.0018	CcSEcCtD
Zanamivir—Infection—Vincristine—peripheral nervous system neoplasm	0.00179	0.00179	CcSEcCtD
Zanamivir—Asthenia—Topotecan—peripheral nervous system neoplasm	0.00179	0.00179	CcSEcCtD
Zanamivir—Anorexia—Alitretinoin—peripheral nervous system neoplasm	0.00179	0.00179	CcSEcCtD
Zanamivir—Increased appetite—Epirubicin—peripheral nervous system neoplasm	0.00178	0.00178	CcSEcCtD
Zanamivir—Asthenia—Tretinoin—peripheral nervous system neoplasm	0.00177	0.00177	CcSEcCtD
Zanamivir—Asthenia—Isotretinoin—peripheral nervous system neoplasm	0.00177	0.00177	CcSEcCtD
Zanamivir—Malaise—Cisplatin—peripheral nervous system neoplasm	0.00176	0.00176	CcSEcCtD
Zanamivir—Decreased appetite—Dactinomycin—peripheral nervous system neoplasm	0.00176	0.00176	CcSEcCtD
Zanamivir—Asthenia—Melphalan—peripheral nervous system neoplasm	0.00175	0.00175	CcSEcCtD
Zanamivir—Fatigue—Dactinomycin—peripheral nervous system neoplasm	0.00174	0.00174	CcSEcCtD
Zanamivir—Pain—Dactinomycin—peripheral nervous system neoplasm	0.00173	0.00173	CcSEcCtD
Zanamivir—Anaphylactoid reaction—Epirubicin—peripheral nervous system neoplasm	0.00172	0.00172	CcSEcCtD
Zanamivir—Anorexia—Vincristine—peripheral nervous system neoplasm	0.00172	0.00172	CcSEcCtD
Zanamivir—Musculoskeletal discomfort—Alitretinoin—peripheral nervous system neoplasm	0.00171	0.00171	CcSEcCtD
Zanamivir—Diarrhoea—Topotecan—peripheral nervous system neoplasm	0.00171	0.00171	CcSEcCtD
Zanamivir—Convulsion—Cisplatin—peripheral nervous system neoplasm	0.0017	0.0017	CcSEcCtD
Zanamivir—Diarrhoea—Tretinoin—peripheral nervous system neoplasm	0.00169	0.00169	CcSEcCtD
Zanamivir—Diarrhoea—Isotretinoin—peripheral nervous system neoplasm	0.00169	0.00169	CcSEcCtD
Zanamivir—Dyspnoea—Alitretinoin—peripheral nervous system neoplasm	0.00167	0.00167	CcSEcCtD
Zanamivir—Diarrhoea—Melphalan—peripheral nervous system neoplasm	0.00167	0.00167	CcSEcCtD
Zanamivir—Myalgia—Cisplatin—peripheral nervous system neoplasm	0.00167	0.00167	CcSEcCtD
Zanamivir—Feeling abnormal—Dactinomycin—peripheral nervous system neoplasm	0.00167	0.00167	CcSEcCtD
Zanamivir—Ill-defined disorder—Etoposide—peripheral nervous system neoplasm	0.00166	0.00166	CcSEcCtD
Zanamivir—Anxiety—Cisplatin—peripheral nervous system neoplasm	0.00166	0.00166	CcSEcCtD
Zanamivir—Unspecified disorder of skin and subcutaneous tissue—Cisplatin—peripheral nervous system neoplasm	0.00165	0.00165	CcSEcCtD
Zanamivir—Gastrointestinal pain—Dactinomycin—peripheral nervous system neoplasm	0.00165	0.00165	CcSEcCtD
Zanamivir—Dizziness—Topotecan—peripheral nervous system neoplasm	0.00165	0.00165	CcSEcCtD
Zanamivir—Discomfort—Cisplatin—peripheral nervous system neoplasm	0.00165	0.00165	CcSEcCtD
Zanamivir—Musculoskeletal discomfort—Vincristine—peripheral nervous system neoplasm	0.00165	0.00165	CcSEcCtD
Zanamivir—Increased appetite—Doxorubicin—peripheral nervous system neoplasm	0.00164	0.00164	CcSEcCtD
Zanamivir—Dizziness—Tretinoin—peripheral nervous system neoplasm	0.00164	0.00164	CcSEcCtD
Zanamivir—Dizziness—Isotretinoin—peripheral nervous system neoplasm	0.00164	0.00164	CcSEcCtD
Zanamivir—Decreased appetite—Alitretinoin—peripheral nervous system neoplasm	0.00163	0.00163	CcSEcCtD
Zanamivir—Malaise—Etoposide—peripheral nervous system neoplasm	0.00162	0.00162	CcSEcCtD
Zanamivir—Fatigue—Alitretinoin—peripheral nervous system neoplasm	0.00162	0.00162	CcSEcCtD
Zanamivir—Face oedema—Epirubicin—peripheral nervous system neoplasm	0.00161	0.00161	CcSEcCtD
Zanamivir—Pain—Alitretinoin—peripheral nervous system neoplasm	0.0016	0.0016	CcSEcCtD
Zanamivir—Abdominal pain—Dactinomycin—peripheral nervous system neoplasm	0.0016	0.0016	CcSEcCtD
Zanamivir—Body temperature increased—Dactinomycin—peripheral nervous system neoplasm	0.0016	0.0016	CcSEcCtD
Zanamivir—Anaphylactic shock—Cisplatin—peripheral nervous system neoplasm	0.0016	0.0016	CcSEcCtD
Zanamivir—Anaphylactoid reaction—Doxorubicin—peripheral nervous system neoplasm	0.0016	0.0016	CcSEcCtD
Zanamivir—Infection—Cisplatin—peripheral nervous system neoplasm	0.00159	0.00159	CcSEcCtD
Zanamivir—Vomiting—Topotecan—peripheral nervous system neoplasm	0.00159	0.00159	CcSEcCtD
Zanamivir—Loss of consciousness—Etoposide—peripheral nervous system neoplasm	0.00158	0.00158	CcSEcCtD
Zanamivir—Vomiting—Tretinoin—peripheral nervous system neoplasm	0.00157	0.00157	CcSEcCtD
Zanamivir—Vomiting—Isotretinoin—peripheral nervous system neoplasm	0.00157	0.00157	CcSEcCtD
Zanamivir—Rash—Topotecan—peripheral nervous system neoplasm	0.00157	0.00157	CcSEcCtD
Zanamivir—Dermatitis—Topotecan—peripheral nervous system neoplasm	0.00157	0.00157	CcSEcCtD
Zanamivir—Decreased appetite—Vincristine—peripheral nervous system neoplasm	0.00157	0.00157	CcSEcCtD
Zanamivir—Cough—Etoposide—peripheral nervous system neoplasm	0.00156	0.00156	CcSEcCtD
Zanamivir—Headache—Topotecan—peripheral nervous system neoplasm	0.00156	0.00156	CcSEcCtD
Zanamivir—Rash—Isotretinoin—peripheral nervous system neoplasm	0.00156	0.00156	CcSEcCtD
Zanamivir—Rash—Tretinoin—peripheral nervous system neoplasm	0.00156	0.00156	CcSEcCtD
Zanamivir—Dermatitis—Tretinoin—peripheral nervous system neoplasm	0.00156	0.00156	CcSEcCtD
Zanamivir—Dermatitis—Isotretinoin—peripheral nervous system neoplasm	0.00156	0.00156	CcSEcCtD
Zanamivir—Fatigue—Vincristine—peripheral nervous system neoplasm	0.00156	0.00156	CcSEcCtD
Zanamivir—Convulsion—Etoposide—peripheral nervous system neoplasm	0.00155	0.00155	CcSEcCtD
Zanamivir—Vomiting—Melphalan—peripheral nervous system neoplasm	0.00155	0.00155	CcSEcCtD
Zanamivir—Dehydration—Epirubicin—peripheral nervous system neoplasm	0.00155	0.00155	CcSEcCtD
Zanamivir—Skin disorder—Cisplatin—peripheral nervous system neoplasm	0.00155	0.00155	CcSEcCtD
Zanamivir—Headache—Tretinoin—peripheral nervous system neoplasm	0.00155	0.00155	CcSEcCtD
Zanamivir—Headache—Isotretinoin—peripheral nervous system neoplasm	0.00155	0.00155	CcSEcCtD
Zanamivir—Feeling abnormal—Alitretinoin—peripheral nervous system neoplasm	0.00154	0.00154	CcSEcCtD
Zanamivir—Pain—Vincristine—peripheral nervous system neoplasm	0.00154	0.00154	CcSEcCtD
Zanamivir—Rash—Melphalan—peripheral nervous system neoplasm	0.00154	0.00154	CcSEcCtD
Zanamivir—Dermatitis—Melphalan—peripheral nervous system neoplasm	0.00154	0.00154	CcSEcCtD
Zanamivir—Gastrointestinal pain—Alitretinoin—peripheral nervous system neoplasm	0.00153	0.00153	CcSEcCtD
Zanamivir—Anorexia—Cisplatin—peripheral nervous system neoplasm	0.00152	0.00152	CcSEcCtD
Zanamivir—Unspecified disorder of skin and subcutaneous tissue—Etoposide—peripheral nervous system neoplasm	0.00152	0.00152	CcSEcCtD
Zanamivir—Discomfort—Etoposide—peripheral nervous system neoplasm	0.00151	0.00151	CcSEcCtD
Zanamivir—Toxic epidermal necrolysis—Epirubicin—peripheral nervous system neoplasm	0.0015	0.0015	CcSEcCtD
Zanamivir—Face oedema—Doxorubicin—peripheral nervous system neoplasm	0.00149	0.00149	CcSEcCtD
Zanamivir—Hypersensitivity—Dactinomycin—peripheral nervous system neoplasm	0.00149	0.00149	CcSEcCtD
Zanamivir—Urticaria—Alitretinoin—peripheral nervous system neoplasm	0.00149	0.00149	CcSEcCtD
Zanamivir—Abdominal pain—Alitretinoin—peripheral nervous system neoplasm	0.00148	0.00148	CcSEcCtD
Zanamivir—Body temperature increased—Alitretinoin—peripheral nervous system neoplasm	0.00148	0.00148	CcSEcCtD
Zanamivir—Nausea—Topotecan—peripheral nervous system neoplasm	0.00148	0.00148	CcSEcCtD
Zanamivir—Gastrointestinal pain—Vincristine—peripheral nervous system neoplasm	0.00148	0.00148	CcSEcCtD
Zanamivir—Confusional state—Etoposide—peripheral nervous system neoplasm	0.00148	0.00148	CcSEcCtD
Zanamivir—Nausea—Tretinoin—peripheral nervous system neoplasm	0.00147	0.00147	CcSEcCtD
Zanamivir—Nausea—Isotretinoin—peripheral nervous system neoplasm	0.00147	0.00147	CcSEcCtD
Zanamivir—Anaphylactic shock—Etoposide—peripheral nervous system neoplasm	0.00146	0.00146	CcSEcCtD
Zanamivir—Musculoskeletal discomfort—Cisplatin—peripheral nervous system neoplasm	0.00145	0.00145	CcSEcCtD
Zanamivir—Infection—Etoposide—peripheral nervous system neoplasm	0.00145	0.00145	CcSEcCtD
Zanamivir—Asthenia—Dactinomycin—peripheral nervous system neoplasm	0.00145	0.00145	CcSEcCtD
Zanamivir—Nausea—Melphalan—peripheral nervous system neoplasm	0.00145	0.00145	CcSEcCtD
Zanamivir—Asthma—Epirubicin—peripheral nervous system neoplasm	0.00144	0.00144	CcSEcCtD
Zanamivir—Influenza—Epirubicin—peripheral nervous system neoplasm	0.00144	0.00144	CcSEcCtD
Zanamivir—Dehydration—Doxorubicin—peripheral nervous system neoplasm	0.00144	0.00144	CcSEcCtD
Zanamivir—Abdominal pain—Vincristine—peripheral nervous system neoplasm	0.00143	0.00143	CcSEcCtD
Zanamivir—Body temperature increased—Vincristine—peripheral nervous system neoplasm	0.00143	0.00143	CcSEcCtD
Zanamivir—Dyspnoea—Cisplatin—peripheral nervous system neoplasm	0.00142	0.00142	CcSEcCtD
Zanamivir—Skin disorder—Etoposide—peripheral nervous system neoplasm	0.00142	0.00142	CcSEcCtD
Zanamivir—Anorexia—Etoposide—peripheral nervous system neoplasm	0.00139	0.00139	CcSEcCtD
Zanamivir—Toxic epidermal necrolysis—Doxorubicin—peripheral nervous system neoplasm	0.00139	0.00139	CcSEcCtD
Zanamivir—Decreased appetite—Cisplatin—peripheral nervous system neoplasm	0.00139	0.00139	CcSEcCtD
Zanamivir—Bronchitis—Epirubicin—peripheral nervous system neoplasm	0.00139	0.00139	CcSEcCtD
Zanamivir—Diarrhoea—Dactinomycin—peripheral nervous system neoplasm	0.00138	0.00138	CcSEcCtD
Zanamivir—Hypersensitivity—Alitretinoin—peripheral nervous system neoplasm	0.00138	0.00138	CcSEcCtD
Zanamivir—Pain—Cisplatin—peripheral nervous system neoplasm	0.00137	0.00137	CcSEcCtD
Zanamivir—Neutropenia—Epirubicin—peripheral nervous system neoplasm	0.00135	0.00135	CcSEcCtD
Zanamivir—Asthenia—Alitretinoin—peripheral nervous system neoplasm	0.00134	0.00134	CcSEcCtD
Zanamivir—Asthma—Doxorubicin—peripheral nervous system neoplasm	0.00133	0.00133	CcSEcCtD
Zanamivir—Influenza—Doxorubicin—peripheral nervous system neoplasm	0.00133	0.00133	CcSEcCtD
Zanamivir—Hypersensitivity—Vincristine—peripheral nervous system neoplasm	0.00133	0.00133	CcSEcCtD
Zanamivir—Feeling abnormal—Cisplatin—peripheral nervous system neoplasm	0.00132	0.00132	CcSEcCtD
Zanamivir—Dyspnoea—Etoposide—peripheral nervous system neoplasm	0.0013	0.0013	CcSEcCtD
Zanamivir—Asthenia—Vincristine—peripheral nervous system neoplasm	0.0013	0.0013	CcSEcCtD
Zanamivir—Vomiting—Dactinomycin—peripheral nervous system neoplasm	0.00129	0.00129	CcSEcCtD
Zanamivir—Bronchitis—Doxorubicin—peripheral nervous system neoplasm	0.00128	0.00128	CcSEcCtD
Zanamivir—Diarrhoea—Alitretinoin—peripheral nervous system neoplasm	0.00128	0.00128	CcSEcCtD
Zanamivir—Stevens-Johnson syndrome—Epirubicin—peripheral nervous system neoplasm	0.00127	0.00127	CcSEcCtD
Zanamivir—Rash—Dactinomycin—peripheral nervous system neoplasm	0.00127	0.00127	CcSEcCtD
Zanamivir—Decreased appetite—Etoposide—peripheral nervous system neoplasm	0.00127	0.00127	CcSEcCtD
Zanamivir—Body temperature increased—Cisplatin—peripheral nervous system neoplasm	0.00126	0.00126	CcSEcCtD
Zanamivir—Fatigue—Etoposide—peripheral nervous system neoplasm	0.00126	0.00126	CcSEcCtD
Zanamivir—Pain—Etoposide—peripheral nervous system neoplasm	0.00125	0.00125	CcSEcCtD
Zanamivir—Neutropenia—Doxorubicin—peripheral nervous system neoplasm	0.00125	0.00125	CcSEcCtD
Zanamivir—Dizziness—Alitretinoin—peripheral nervous system neoplasm	0.00124	0.00124	CcSEcCtD
Zanamivir—Diarrhoea—Vincristine—peripheral nervous system neoplasm	0.00124	0.00124	CcSEcCtD
Zanamivir—Sinusitis—Epirubicin—peripheral nervous system neoplasm	0.00121	0.00121	CcSEcCtD
Zanamivir—Feeling abnormal—Etoposide—peripheral nervous system neoplasm	0.00121	0.00121	CcSEcCtD
Zanamivir—Nausea—Dactinomycin—peripheral nervous system neoplasm	0.0012	0.0012	CcSEcCtD
Zanamivir—Gastrointestinal pain—Etoposide—peripheral nervous system neoplasm	0.0012	0.0012	CcSEcCtD
Zanamivir—Dizziness—Vincristine—peripheral nervous system neoplasm	0.00119	0.00119	CcSEcCtD
Zanamivir—Vomiting—Alitretinoin—peripheral nervous system neoplasm	0.00119	0.00119	CcSEcCtD
Zanamivir—Rash—Alitretinoin—peripheral nervous system neoplasm	0.00118	0.00118	CcSEcCtD
Zanamivir—Dermatitis—Alitretinoin—peripheral nervous system neoplasm	0.00118	0.00118	CcSEcCtD
Zanamivir—Stevens-Johnson syndrome—Doxorubicin—peripheral nervous system neoplasm	0.00118	0.00118	CcSEcCtD
Zanamivir—Hypersensitivity—Cisplatin—peripheral nervous system neoplasm	0.00118	0.00118	CcSEcCtD
Zanamivir—Headache—Alitretinoin—peripheral nervous system neoplasm	0.00117	0.00117	CcSEcCtD
Zanamivir—Urticaria—Etoposide—peripheral nervous system neoplasm	0.00116	0.00116	CcSEcCtD
Zanamivir—Haemoglobin—Epirubicin—peripheral nervous system neoplasm	0.00116	0.00116	CcSEcCtD
Zanamivir—Abdominal pain—Etoposide—peripheral nervous system neoplasm	0.00116	0.00116	CcSEcCtD
Zanamivir—Body temperature increased—Etoposide—peripheral nervous system neoplasm	0.00116	0.00116	CcSEcCtD
Zanamivir—Haemorrhage—Epirubicin—peripheral nervous system neoplasm	0.00115	0.00115	CcSEcCtD
Zanamivir—Vomiting—Vincristine—peripheral nervous system neoplasm	0.00115	0.00115	CcSEcCtD
Zanamivir—Asthenia—Cisplatin—peripheral nervous system neoplasm	0.00115	0.00115	CcSEcCtD
Zanamivir—Rash—Vincristine—peripheral nervous system neoplasm	0.00114	0.00114	CcSEcCtD
Zanamivir—Dermatitis—Vincristine—peripheral nervous system neoplasm	0.00114	0.00114	CcSEcCtD
Zanamivir—Headache—Vincristine—peripheral nervous system neoplasm	0.00113	0.00113	CcSEcCtD
Zanamivir—Sinusitis—Doxorubicin—peripheral nervous system neoplasm	0.00112	0.00112	CcSEcCtD
Zanamivir—Nausea—Alitretinoin—peripheral nervous system neoplasm	0.00111	0.00111	CcSEcCtD
Zanamivir—Diarrhoea—Cisplatin—peripheral nervous system neoplasm	0.00109	0.00109	CcSEcCtD
Zanamivir—Erythema multiforme—Epirubicin—peripheral nervous system neoplasm	0.00109	0.00109	CcSEcCtD
Zanamivir—Hypersensitivity—Etoposide—peripheral nervous system neoplasm	0.00108	0.00108	CcSEcCtD
Zanamivir—Haemoglobin—Doxorubicin—peripheral nervous system neoplasm	0.00107	0.00107	CcSEcCtD
Zanamivir—Nausea—Vincristine—peripheral nervous system neoplasm	0.00107	0.00107	CcSEcCtD
Zanamivir—Haemorrhage—Doxorubicin—peripheral nervous system neoplasm	0.00107	0.00107	CcSEcCtD
Zanamivir—Asthenia—Etoposide—peripheral nervous system neoplasm	0.00105	0.00105	CcSEcCtD
Zanamivir—Chills—Epirubicin—peripheral nervous system neoplasm	0.00104	0.00104	CcSEcCtD
Zanamivir—Arrhythmia—Epirubicin—peripheral nervous system neoplasm	0.00103	0.00103	CcSEcCtD
Zanamivir—Vomiting—Cisplatin—peripheral nervous system neoplasm	0.00102	0.00102	CcSEcCtD
Zanamivir—Erythema multiforme—Doxorubicin—peripheral nervous system neoplasm	0.00101	0.00101	CcSEcCtD
Zanamivir—Rash—Cisplatin—peripheral nervous system neoplasm	0.00101	0.00101	CcSEcCtD
Zanamivir—Dermatitis—Cisplatin—peripheral nervous system neoplasm	0.00101	0.00101	CcSEcCtD
Zanamivir—Diarrhoea—Etoposide—peripheral nervous system neoplasm	0.001	0.001	CcSEcCtD
Zanamivir—Dizziness—Etoposide—peripheral nervous system neoplasm	0.000967	0.000967	CcSEcCtD
Zanamivir—Chills—Doxorubicin—peripheral nervous system neoplasm	0.000958	0.000958	CcSEcCtD
Zanamivir—Arrhythmia—Doxorubicin—peripheral nervous system neoplasm	0.000954	0.000954	CcSEcCtD
Zanamivir—Nausea—Cisplatin—peripheral nervous system neoplasm	0.000949	0.000949	CcSEcCtD
Zanamivir—Ill-defined disorder—Epirubicin—peripheral nervous system neoplasm	0.000932	0.000932	CcSEcCtD
Zanamivir—Vomiting—Etoposide—peripheral nervous system neoplasm	0.00093	0.00093	CcSEcCtD
Zanamivir—Agitation—Epirubicin—peripheral nervous system neoplasm	0.000923	0.000923	CcSEcCtD
Zanamivir—Rash—Etoposide—peripheral nervous system neoplasm	0.000922	0.000922	CcSEcCtD
Zanamivir—Dermatitis—Etoposide—peripheral nervous system neoplasm	0.000922	0.000922	CcSEcCtD
Zanamivir—Headache—Etoposide—peripheral nervous system neoplasm	0.000916	0.000916	CcSEcCtD
Zanamivir—Malaise—Epirubicin—peripheral nervous system neoplasm	0.000906	0.000906	CcSEcCtD
Zanamivir—Syncope—Epirubicin—peripheral nervous system neoplasm	0.000901	0.000901	CcSEcCtD
Zanamivir—Loss of consciousness—Epirubicin—peripheral nervous system neoplasm	0.000883	0.000883	CcSEcCtD
Zanamivir—Cough—Epirubicin—peripheral nervous system neoplasm	0.000877	0.000877	CcSEcCtD
Zanamivir—Convulsion—Epirubicin—peripheral nervous system neoplasm	0.000871	0.000871	CcSEcCtD
Zanamivir—Nausea—Etoposide—peripheral nervous system neoplasm	0.000869	0.000869	CcSEcCtD
Zanamivir—Ill-defined disorder—Doxorubicin—peripheral nervous system neoplasm	0.000863	0.000863	CcSEcCtD
Zanamivir—Myalgia—Epirubicin—peripheral nervous system neoplasm	0.000855	0.000855	CcSEcCtD
Zanamivir—Arthralgia—Epirubicin—peripheral nervous system neoplasm	0.000855	0.000855	CcSEcCtD
Zanamivir—Agitation—Doxorubicin—peripheral nervous system neoplasm	0.000854	0.000854	CcSEcCtD
Zanamivir—Anxiety—Epirubicin—peripheral nervous system neoplasm	0.000853	0.000853	CcSEcCtD
Zanamivir—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—peripheral nervous system neoplasm	0.00085	0.00085	CcSEcCtD
Zanamivir—Discomfort—Epirubicin—peripheral nervous system neoplasm	0.000845	0.000845	CcSEcCtD
Zanamivir—Malaise—Doxorubicin—peripheral nervous system neoplasm	0.000838	0.000838	CcSEcCtD
Zanamivir—Syncope—Doxorubicin—peripheral nervous system neoplasm	0.000834	0.000834	CcSEcCtD
Zanamivir—Confusional state—Epirubicin—peripheral nervous system neoplasm	0.000827	0.000827	CcSEcCtD
Zanamivir—Anaphylactic shock—Epirubicin—peripheral nervous system neoplasm	0.00082	0.00082	CcSEcCtD
Zanamivir—Loss of consciousness—Doxorubicin—peripheral nervous system neoplasm	0.000817	0.000817	CcSEcCtD
Zanamivir—Infection—Epirubicin—peripheral nervous system neoplasm	0.000815	0.000815	CcSEcCtD
Zanamivir—Cough—Doxorubicin—peripheral nervous system neoplasm	0.000811	0.000811	CcSEcCtD
Zanamivir—Shock—Epirubicin—peripheral nervous system neoplasm	0.000807	0.000807	CcSEcCtD
Zanamivir—Convulsion—Doxorubicin—peripheral nervous system neoplasm	0.000806	0.000806	CcSEcCtD
Zanamivir—Skin disorder—Epirubicin—peripheral nervous system neoplasm	0.000797	0.000797	CcSEcCtD
Zanamivir—Myalgia—Doxorubicin—peripheral nervous system neoplasm	0.000792	0.000792	CcSEcCtD
Zanamivir—Arthralgia—Doxorubicin—peripheral nervous system neoplasm	0.000792	0.000792	CcSEcCtD
Zanamivir—Anxiety—Doxorubicin—peripheral nervous system neoplasm	0.000789	0.000789	CcSEcCtD
Zanamivir—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—peripheral nervous system neoplasm	0.000786	0.000786	CcSEcCtD
Zanamivir—Discomfort—Doxorubicin—peripheral nervous system neoplasm	0.000782	0.000782	CcSEcCtD
Zanamivir—Anorexia—Epirubicin—peripheral nervous system neoplasm	0.000782	0.000782	CcSEcCtD
Zanamivir—Confusional state—Doxorubicin—peripheral nervous system neoplasm	0.000765	0.000765	CcSEcCtD
Zanamivir—Anaphylactic shock—Doxorubicin—peripheral nervous system neoplasm	0.000759	0.000759	CcSEcCtD
Zanamivir—Infection—Doxorubicin—peripheral nervous system neoplasm	0.000754	0.000754	CcSEcCtD
Zanamivir—Musculoskeletal discomfort—Epirubicin—peripheral nervous system neoplasm	0.000747	0.000747	CcSEcCtD
Zanamivir—Shock—Doxorubicin—peripheral nervous system neoplasm	0.000747	0.000747	CcSEcCtD
Zanamivir—Skin disorder—Doxorubicin—peripheral nervous system neoplasm	0.000737	0.000737	CcSEcCtD
Zanamivir—Dyspnoea—Epirubicin—peripheral nervous system neoplasm	0.000731	0.000731	CcSEcCtD
Zanamivir—Anorexia—Doxorubicin—peripheral nervous system neoplasm	0.000723	0.000723	CcSEcCtD
Zanamivir—Decreased appetite—Epirubicin—peripheral nervous system neoplasm	0.000713	0.000713	CcSEcCtD
Zanamivir—Fatigue—Epirubicin—peripheral nervous system neoplasm	0.000707	0.000707	CcSEcCtD
Zanamivir—Pain—Epirubicin—peripheral nervous system neoplasm	0.000701	0.000701	CcSEcCtD
Zanamivir—Musculoskeletal discomfort—Doxorubicin—peripheral nervous system neoplasm	0.000691	0.000691	CcSEcCtD
Zanamivir—Dyspnoea—Doxorubicin—peripheral nervous system neoplasm	0.000676	0.000676	CcSEcCtD
Zanamivir—Feeling abnormal—Epirubicin—peripheral nervous system neoplasm	0.000676	0.000676	CcSEcCtD
Zanamivir—Gastrointestinal pain—Epirubicin—peripheral nervous system neoplasm	0.000671	0.000671	CcSEcCtD
Zanamivir—Decreased appetite—Doxorubicin—peripheral nervous system neoplasm	0.00066	0.00066	CcSEcCtD
Zanamivir—Fatigue—Doxorubicin—peripheral nervous system neoplasm	0.000654	0.000654	CcSEcCtD
Zanamivir—Urticaria—Epirubicin—peripheral nervous system neoplasm	0.000651	0.000651	CcSEcCtD
Zanamivir—Pain—Doxorubicin—peripheral nervous system neoplasm	0.000649	0.000649	CcSEcCtD
Zanamivir—Abdominal pain—Epirubicin—peripheral nervous system neoplasm	0.000648	0.000648	CcSEcCtD
Zanamivir—Body temperature increased—Epirubicin—peripheral nervous system neoplasm	0.000648	0.000648	CcSEcCtD
Zanamivir—Feeling abnormal—Doxorubicin—peripheral nervous system neoplasm	0.000625	0.000625	CcSEcCtD
Zanamivir—Gastrointestinal pain—Doxorubicin—peripheral nervous system neoplasm	0.00062	0.00062	CcSEcCtD
Zanamivir—Hypersensitivity—Epirubicin—peripheral nervous system neoplasm	0.000604	0.000604	CcSEcCtD
Zanamivir—Urticaria—Doxorubicin—peripheral nervous system neoplasm	0.000603	0.000603	CcSEcCtD
Zanamivir—Abdominal pain—Doxorubicin—peripheral nervous system neoplasm	0.0006	0.0006	CcSEcCtD
Zanamivir—Body temperature increased—Doxorubicin—peripheral nervous system neoplasm	0.0006	0.0006	CcSEcCtD
Zanamivir—Asthenia—Epirubicin—peripheral nervous system neoplasm	0.000588	0.000588	CcSEcCtD
Zanamivir—Diarrhoea—Epirubicin—peripheral nervous system neoplasm	0.000561	0.000561	CcSEcCtD
Zanamivir—Hypersensitivity—Doxorubicin—peripheral nervous system neoplasm	0.000559	0.000559	CcSEcCtD
Zanamivir—Asthenia—Doxorubicin—peripheral nervous system neoplasm	0.000544	0.000544	CcSEcCtD
Zanamivir—Dizziness—Epirubicin—peripheral nervous system neoplasm	0.000542	0.000542	CcSEcCtD
Zanamivir—Vomiting—Epirubicin—peripheral nervous system neoplasm	0.000521	0.000521	CcSEcCtD
Zanamivir—Diarrhoea—Doxorubicin—peripheral nervous system neoplasm	0.000519	0.000519	CcSEcCtD
Zanamivir—Rash—Epirubicin—peripheral nervous system neoplasm	0.000517	0.000517	CcSEcCtD
Zanamivir—Dermatitis—Epirubicin—peripheral nervous system neoplasm	0.000517	0.000517	CcSEcCtD
Zanamivir—Headache—Epirubicin—peripheral nervous system neoplasm	0.000514	0.000514	CcSEcCtD
Zanamivir—Dizziness—Doxorubicin—peripheral nervous system neoplasm	0.000502	0.000502	CcSEcCtD
Zanamivir—Nausea—Epirubicin—peripheral nervous system neoplasm	0.000487	0.000487	CcSEcCtD
Zanamivir—Vomiting—Doxorubicin—peripheral nervous system neoplasm	0.000482	0.000482	CcSEcCtD
Zanamivir—Rash—Doxorubicin—peripheral nervous system neoplasm	0.000478	0.000478	CcSEcCtD
Zanamivir—Dermatitis—Doxorubicin—peripheral nervous system neoplasm	0.000478	0.000478	CcSEcCtD
Zanamivir—Headache—Doxorubicin—peripheral nervous system neoplasm	0.000475	0.000475	CcSEcCtD
Zanamivir—Nausea—Doxorubicin—peripheral nervous system neoplasm	0.000451	0.000451	CcSEcCtD
